Peter A Humphrey

Author PubWeight™ 109.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004 5.13
2 Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007 3.54
3 The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol 2016 2.94
4 Effect of reclassification on the incidence of benign and malignant renal tumors. J Urol 2009 2.67
5 Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies. Am J Surg Pathol 2010 2.16
6 Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 2006 2.13
7 The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 2013 2.05
8 Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am J Surg Pathol 2007 1.92
9 Evaluation of a vessel sealing system, bipolar electrosurgery, harmonic scalpel, titanium clips, endoscopic gastrointestinal anastomosis vascular staples and sutures for arterial and venous ligation in a porcine model. J Urol 2003 1.84
10 Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol 2002 1.83
11 The Gleason score of tumor at the margin in radical prostatectomy is predictive of biochemical recurrence. Am J Surg Pathol 2010 1.61
12 Tumor volume in prostate cancer and serum prostate-specific antigen. Analysis from a kinetic viewpoint. Am J Clin Pathol 2003 1.60
13 SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 2009 1.59
14 A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. Eur Urol 2012 1.56
15 Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 2005 1.54
16 Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology 2013 1.53
17 Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am J Surg Pathol 2008 1.49
18 Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study. Am J Surg Pathol 2002 1.48
19 Ability of linear length of positive margin in radical prostatectomy specimens to predict biochemical recurrence. Urology 2011 1.43
20 Prostatic tissue in testicular teratoma. A clinicopathologic and immunohistochemical study. Ann Diagn Pathol 2012 1.43
21 Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification. J Urol 2005 1.43
22 Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol 2006 1.42
23 Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features. Urology 2002 1.41
24 Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice. J Biol Chem 2002 1.40
25 SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol 2009 1.39
26 Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol 2010 1.39
27 Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 2009 1.38
28 Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 2004 1.24
29 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 2010 1.22
30 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 2010 1.22
31 Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol 2005 1.20
32 Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med 2009 1.17
33 The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation. Arch Pathol Lab Med 2014 1.17
34 Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol 2004 1.17
35 Neoplasms of the perivascular epithelioid cell involving the abdomen and the pelvis: cross-sectional imaging findings. J Comput Assist Tomogr 2007 1.16
36 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 2010 1.12
37 Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med 2009 1.10
38 Evaluation of surgical energy devices for vessel sealing and peripheral energy spread in a porcine model. J Urol 2007 1.10
39 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol 2010 1.09
40 Evaluation of a novel knotless self-anchoring suture material for urinary tract reconstruction. Urology 2006 1.08
41 Tissue response to surgical energy devices. Urology 2008 1.07
42 International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol 2010 1.07
43 Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. Urology 2007 1.05
44 Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol 2005 1.03
45 Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 2005 1.01
46 Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014 1.00
47 The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol 2008 0.99
48 Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? Urology 2004 0.97
49 Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma. Urology 2008 0.95
50 Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues. Am J Surg Pathol 2005 0.94
51 Pseudoneoplastic mimics of prostate and bladder carcinomas. Arch Pathol Lab Med 2010 0.94
52 High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. Urology 2005 0.93
53 Expression of beta-catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas. Am J Clin Pathol 2004 0.91
54 Exaggerated signet-ring cell change in stromal nodule of prostate: a pseudoneoplastic proliferation. Am J Surg Pathol 2002 0.91
55 Basal cell hyperplasia in the peripheral zone of the prostate. Mod Pathol 2003 0.91
56 Low frequency of epigenetic events in urothelial tumors in young patients. J Urol 2010 0.88
57 Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate. Mod Pathol 2009 0.88
58 The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection. Urol Oncol 2009 0.88
59 The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol 2002 0.88
60 Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med 2010 0.87
61 Determination of cell viability after laparoscopic tissue stapling in a porcine model. J Endourol 2005 0.87
62 Yolk sac tumor of the testis. J Urol 2011 0.86
63 Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland. Arch Pathol Lab Med 2006 0.86
64 Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors. Cancer 2002 0.83
65 Maternal high-fat diet induces hyperproliferation and alters Pten/Akt signaling in prostates of offspring. Sci Rep 2013 0.83
66 Neoplasms of the renal medulla: radiologic-pathologic correlation. Radiographics 2005 0.83
67 [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]. Verh Dtsch Ges Pathol 2006 0.82
68 Precise characterization of renal parenchymal response to single and multiple cryoablation probes. J Urol 2006 0.82
69 Active surveillance for prostate cancer: the role of the pathologist. Pathology 2015 0.82
70 Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists. Histopathology 2014 0.81
71 Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol 2003 0.81
72 Ductal adenocarcinoma of the prostate. J Urol 2011 0.81
73 Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol 2015 0.81
74 Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Virchows Arch 2014 0.81
75 Evaluation of synchronous twin pulse technique for shock wave lithotripsy: in vivo tissue effects. Urology 2003 0.80
76 Stratified epithelium in prostatic adenocarcinoma: a mimic of high-grade prostatic intraepithelial neoplasia. Mod Pathol 2006 0.80
77 Updated protocol for the examination of specimens from patients with carcinoma of the urinary bladder, ureter, and renal pelvis. Arch Pathol Lab Med 2003 0.80
78 Tumor amount in prostatic tissues in relation to patient outcome and management. Am J Clin Pathol 2009 0.80
79 Foamy gland adenocarcinoma of the prostate: incidence, Gleason grade, and early clinical outcome. Hum Pathol 2012 0.79
80 Gene expression profiles and differential cytoglobin expression in atrophy and adenocarcinoma of the prostate. Prostate 2011 0.79
81 t(X;18) reverse transcriptase-polymerase chain reaction demonstrating a variant transcript. J Mol Diagn 2002 0.79
82 Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue. Am J Surg Pathol 2014 0.79
83 Laparoscopic mid sagittal hemicystectomy and bladder reconstruction with small intestinal submucosa and reimplantation of ureter into small intestinal submucosa: 1-year followup. J Urol 2004 0.79
84 Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression. Am J Surg Pathol 2013 0.79
85 Bladder lymphoma. J Urol 2012 0.79
86 High-grade prostate cancer in the Prostate Cancer Prevention Trial: fact or artifact? J Natl Cancer Inst 2007 0.79
87 Enhanced renal parenchymal cryoablation with novel 17-gauge cryoprobes. Urology 2004 0.78
88 Prognostic and predictive factors in prostate cancer: historical perspectives and recent international consensus initiatives. Scand J Urol Nephrol Suppl 2005 0.78
89 Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma. Cancer 2008 0.78
90 Carcinoma extent in prostate needle biopsy tissue in the prediction of whole gland tumor volume in a screening population. Am J Clin Pathol 2002 0.78
91 Renal hypothermia achieved by retrograde intracavitary saline perfusion. J Endourol 2002 0.78
92 p63/AMACR antibody cocktail restaining of prostate needle biopsy tissues after transfer to charged slides: a viable approach in the diagnosis of small atypical foci that are lost on block sectioning. Am J Clin Pathol 2005 0.78
93 Pilot study evaluating ureteric physiological changes with a novel 'ribbon stent' design using electromyographic and giant magnetoresistive sensors. BJU Int 2008 0.77
94 Immunohistochemical evaluation of prostate needle biopsies using saved interval sections vs new recut sections from the block: a prospective comparison. Am J Clin Pathol 2009 0.76
95 Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference. Am J Surg Pathol 2014 0.76
96 Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2017 0.75
97 Hybrid renal tumors in Birt-Hogg-Dubé syndrome. J Urol 2011 0.75
98 Transcripts, transcripts, everywhere. Adv Anat Pathol 2002 0.75
99 Protocol for the examination of specimens from patients with carcinoma of the urethra. Arch Pathol Lab Med 2010 0.75
100 Protocol for the examination of specimens from patients with carcinoma of the penis. Arch Pathol Lab Med 2010 0.75
101 Open versus laparoscopic retroperitoneal lymph node dissection: assessing adequacy of dissection in a porcine model. J Endourol 2009 0.75
102 Bile duct-like differentiation in teratoma: a clinicopathologic and immunohistochemical study. Ann Diagn Pathol 2010 0.75
103 Diagnostic anatomic pathology in the era of molecular medicine. Mo Med 2010 0.75
104 Outcome for repeated biopsy of the prostate: roles of serum PSA, small atypical glands, and prostatic intraepithelial neoplasia. Am J Clin Pathol 2007 0.75
105 Recurrent and metastatic malignant melanoma of the penis. J Urol 2012 0.75
106 Adenocarcinoma in an ileal conduit. J Urol 2012 0.75
107 Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns. Am J Surg Pathol 2010 0.75
108 Nonspecific granulomatous prostatitis. J Urol 2012 0.75
109 Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue. Am J Surg Pathol 2012 0.75